Literature DB >> 33540650

Differential Expression of Serum Exosome microRNAs and Cytokines in Influenza A and B Patients Collected in the 2016 and 2017 Influenza Seasons.

Sreekumar Othumpangat1, William G Lindsley1, Donald H Beezhold1, Michael L Kashon2, Carmen N Burrell3,4, Samira Mubareka5, John D Noti1.   

Abstract

MicroRNAs (miRNAs) have remarkable stability and are key regulators of mRNA transcripts for several essential proteins required for the survival of cells and replication of the virus. Exosomes are thought to play an essential role in intercellular communications by transporting proteins and miRNAs, making them ideal in the search for biomarkers. Evidence suggests that miRNAs are involved in the regulation of influenza virus replication in many cell types. During the 2016 and 2017 influenza season, we collected blood samples from 54 patients infected with influenza and from 30 healthy volunteers to identify the potential role of circulating serum miRNAs and cytokines in influenza infection. Data comparing the exosomal miRNAs in patients with influenza B to healthy volunteers showed 76 miRNAs that were differentially expressed (p < 0.05). In contrast, 26 miRNAs were differentially expressed between patients with influenza A (p < 0.05) and the controls. Of these miRNAs, 11 were commonly expressed in both the influenza A and B patients. Interferon (IFN)-inducing protein 10 (IP-10), which is involved in IFN synthesis during influenza infection, showed the highest level of expression in both influenza A and B patients. Influenza A patients showed increased expression of IFNα, GM-CSF, interleukin (IL)-13, IL-17A, IL-1β, IL-6 and TNFα, while influenza B induced increased levels of EGF, G-CSF, IL-1α, MIP-1α, and TNF-β. In addition, hsa-miR-326, hsa-miR-15b-5p, hsa-miR-885, hsa-miR-122-5p, hsa-miR-133a-3p, and hsa-miR-150-5p showed high correlations to IL-6, IL-15, IL-17A, IL-1β, and monocyte chemoattractant protein-1 (MCP-1) with both strains of influenza. Next-generation sequencing studies of H1N1-infected human lung small airway epithelial cells also showed similar pattern of expression of miR-375-5p, miR-143-3p, 199a-3p, and miR-199a-5p compared to influenza A patients. In summary, this study provides insights into the miRNA profiling in both influenza A and B virus in circulation and a novel approach to identify the early infections through a combination of cytokines and miRNA expression.

Entities:  

Keywords:  cytokines; exosome; influenza virus; microRNA; serum

Year:  2021        PMID: 33540650      PMCID: PMC7912959          DOI: 10.3390/pathogens10020149

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  41 in total

1.  Expression of cytokines on human bronchial epithelial cells induced by influenza virus A.

Authors:  M Adachi; S Matsukura; H Tokunaga; F Kokubu
Journal:  Int Arch Allergy Immunol       Date:  1997 May-Jul       Impact factor: 2.749

2.  Influenza A virus infection of human respiratory cells induces primary microRNA expression.

Authors:  William A Buggele; Karen E Johnson; Curt M Horvath
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

3.  The microRNA spectrum in 12 body fluids.

Authors:  Jessica A Weber; David H Baxter; Shile Zhang; David Y Huang; Kuo How Huang; Ming Jen Lee; David J Galas; Kai Wang
Journal:  Clin Chem       Date:  2010-09-16       Impact factor: 8.327

Review 4.  Extracellular microRNA: a new source of biomarkers.

Authors:  Alton Etheridge; Inyoul Lee; Leroy Hood; David Galas; Kai Wang
Journal:  Mutat Res       Date:  2011-03-23       Impact factor: 2.433

Review 5.  Monocyte chemoattractant protein-1 (MCP-1): an overview.

Authors:  Satish L Deshmane; Sergey Kremlev; Shohreh Amini; Bassel E Sawaya
Journal:  J Interferon Cytokine Res       Date:  2009-06       Impact factor: 2.607

6.  Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent.

Authors:  Mitra Esfandiarei; Honglin Luo; Bobby Yanagawa; Agripina Suarez; Darya Dabiri; Jianchang Zhang; Bruce M McManus
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Characterization of extracellular circulating microRNA.

Authors:  Andrey Turchinovich; Ludmila Weiz; Anne Langheinz; Barbara Burwinkel
Journal:  Nucleic Acids Res       Date:  2011-05-24       Impact factor: 16.971

8.  Local and Systemic Immune Responses to Influenza A Virus Infection in Pneumonia and Encephalitis Mouse Models.

Authors:  Yoshiharu Nagaoka; Nobuyuki Nosaka; Mutsuko Yamada; Masato Yashiro; Yosuke Washio; Kenji Baba; Tsuneo Morishima; Hirokazu Tsukahara
Journal:  Dis Markers       Date:  2017-08-24       Impact factor: 3.434

9.  Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer.

Authors:  Milosz Wilczynski; Justyna Danielska; Monika Dzieniecka; Bozena Szymanska; Michal Wojciechowski; Andrzej Malinowski
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

10.  Re-emergence of fatal human influenza A subtype H5N1 disease.

Authors:  J S M Peiris; W C Yu; C W Leung; C Y Cheung; W F Ng; J M Nicholls; T K Ng; K H Chan; S T Lai; W L Lim; K Y Yuen; Y Guan
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

View more
  3 in total

1.  Characteristics of the MicroRNA Expression Profile of Exosomes Released by Vero Cells Infected with Porcine Epidemic Diarrhea Virus.

Authors:  Lei Yin; Xuehuai Shen; Dongdong Yin; Jieru Wang; Ruihong Zhao; Yin Dai; Xiaocheng Pan
Journal:  Viruses       Date:  2022-04-13       Impact factor: 5.818

2.  Influenza Virus-Induced Novel miRNAs Regulate the STAT Pathway.

Authors:  Sreekumar Othumpangat; Donald H Beezhold; Christina M Umbright; John D Noti
Journal:  Viruses       Date:  2021-05-23       Impact factor: 5.048

3.  Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.

Authors:  Ryan J Farr; Christina L Rootes; Louise C Rowntree; Thi H O Nguyen; Luca Hensen; Lukasz Kedzierski; Allen C Cheng; Katherine Kedzierska; Gough G Au; Glenn A Marsh; Seshadri S Vasan; Chwan Hong Foo; Christopher Cowled; Cameron R Stewart
Journal:  PLoS Pathog       Date:  2021-07-28       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.